Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2019)

Akebia Therapeutics (AKBA) has 7 years of Short-term Investments data on file, last reported at $245000.0 in Q4 2019.

• Short-term Investments for Q4 2019 came in at $245000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2019 was $245000.0 (changed 0.0% YoY), and the FY2019 annual result was $245000.0, changed 0.0% from the prior year.
• Short-term Investments fell to $245000.0 in Q4 2019 per AKBA's latest filing, from $22.7 million in the prior quarter.
• Over five years, Short-term Investments peaked at $240.1 million in Q3 2017 and troughed at $245000.0 in Q4 2018.
• A 5-year average of $114.0 million and a median of $93.1 million in 2015 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2015 and 2018: Short-term Investments surged 574.61% in 2015, then plunged 99.58% in 2018.
• A 5-year view of Short-term Investments shows it stood at $88.7 million in 2015, then retreated by 17.67% to $73.0 million in 2016, then fell by 19.58% to $58.7 million in 2017, then sank by 99.58% to $245000.0 in 2018, then changed by 0.0% to $245000.0 in 2019.
• Business Quant data shows AKBA's Short-term Investments at $245000.0 in Q4 2019, $22.7 million in Q3 2019, and $49.6 million in Q2 2019.